Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03947255 |
|---|---|
| Brief Title: | A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma |
| First Submitted : | May 9, 2019 |
| First Submitted that Met QC Criteria : | May 9, 2019 |
| First Posted : | May 13, 2019 |
| Last Update Submitted that Met QC Criteria : | December 7, 2020 |
| Last Update Posted : | December 9, 2020 |